310 related articles for article (PubMed ID: 35335347)
21. Computational medicinal chemistry in fragment-based drug discovery: what, how and when.
Rabal O; Urbano-Cuadrado M; Oyarzabal J
Future Med Chem; 2011 Jan; 3(1):95-134. PubMed ID: 21428828
[TBL] [Abstract][Full Text] [Related]
22. Pushing the Ligand Efficiency Metrics: Relative Group Contribution (RGC) Model as a Helpful Strategy to Promote a Fragment "Rescue" Effect.
Vásquez AF; González Barrios A
Front Chem; 2019; 7():564. PubMed ID: 31482085
[TBL] [Abstract][Full Text] [Related]
23. Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges.
Togre NS; Vargas AM; Bhargavi G; Mallakuntla MK; Tiwari S
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142582
[TBL] [Abstract][Full Text] [Related]
24. Molecular-Simulation-Driven Fragment Screening for the Discovery of New CXCL12 Inhibitors.
Martinez-Rosell G; Harvey MJ; De Fabritiis G
J Chem Inf Model; 2018 Mar; 58(3):683-691. PubMed ID: 29481075
[TBL] [Abstract][Full Text] [Related]
25. Ligand efficiency and fragment-based drug discovery.
Bembenek SD; Tounge BA; Reynolds CH
Drug Discov Today; 2009 Mar; 14(5-6):278-83. PubMed ID: 19073276
[TBL] [Abstract][Full Text] [Related]
26. Applications of Solution NMR in Drug Discovery.
Shi L; Zhang N
Molecules; 2021 Jan; 26(3):. PubMed ID: 33499337
[TBL] [Abstract][Full Text] [Related]
27. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
Reitz AB; Smith GR; Tounge BA; Reynolds CH
Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
[TBL] [Abstract][Full Text] [Related]
28. Novel approach of fragment-based lead discovery applied to renin inhibitors.
Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
[TBL] [Abstract][Full Text] [Related]
29. From Protein Structure to Small-Molecules: Recent Advances and Applications to Fragment-Based Drug Discovery.
Ferreira LG; Andricopulo AD
Curr Top Med Chem; 2017; 17(20):2260-2270. PubMed ID: 28240184
[TBL] [Abstract][Full Text] [Related]
30. Library Design Strategies To Accelerate Fragment-Based Drug Discovery.
Troelsen NS; Clausen MH
Chemistry; 2020 Sep; 26(50):11391-11403. PubMed ID: 32339336
[TBL] [Abstract][Full Text] [Related]
31. Fragment-based drug discovery using rational design.
Jhoti H
Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
[TBL] [Abstract][Full Text] [Related]
32. Binding thermodynamics discriminates fragments from druglike compounds: a thermodynamic description of fragment-based drug discovery.
Williams G; Ferenczy GG; Ulander J; Keserű GM
Drug Discov Today; 2017 Apr; 22(4):681-689. PubMed ID: 27916639
[TBL] [Abstract][Full Text] [Related]
33. Streamlining Computational Fragment-Based Drug Discovery through Evolutionary Optimization Informed by Ligand-Based Virtual Prescreening.
Chandraghatgi R; Ji HF; Rosen GL; Sokhansanj BA
J Chem Inf Model; 2024 May; 64(9):3826-3840. PubMed ID: 38696451
[TBL] [Abstract][Full Text] [Related]
34. Application of Fragment-Based Drug Discovery to Versatile Targets.
Li Q
Front Mol Biosci; 2020; 7():180. PubMed ID: 32850968
[TBL] [Abstract][Full Text] [Related]
35. Virtual fragment preparation for computational fragment-based drug design.
Ludington JL
Methods Mol Biol; 2015; 1289():31-41. PubMed ID: 25709031
[TBL] [Abstract][Full Text] [Related]
36. Fragment-based drug discovery and its application to challenging drug targets.
Price AJ; Howard S; Cons BD
Essays Biochem; 2017 Nov; 61(5):475-484. PubMed ID: 29118094
[TBL] [Abstract][Full Text] [Related]
37. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
Maurer T
Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
[TBL] [Abstract][Full Text] [Related]
38. Towards systematic exploration of chemical space: building the fragment library module in molecular property diagnostic suite.
Gaur AS; John L; Kumar N; Vivek MR; Nagamani S; Mahanta HJ; Sastry GN
Mol Divers; 2023 Jun; 27(3):1459-1468. PubMed ID: 35925528
[TBL] [Abstract][Full Text] [Related]
39. Fragment-based drug discovery-the importance of high-quality molecule libraries.
Bon M; Bilsland A; Bower J; McAulay K
Mol Oncol; 2022 Nov; 16(21):3761-3777. PubMed ID: 35749608
[TBL] [Abstract][Full Text] [Related]
40. [In-Silico Drug Discovery Support-Current Situation and Challenges].
Hirokawa T
Gan To Kagaku Ryoho; 2022 Apr; 49(4):359-364. PubMed ID: 35444115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
